July 05, 2024
2 min watch
Save
VIDEO: Kriya reviews geographic atrophy, thyroid eye disease gene therapies
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Shankar Ramaswamy, MD, of Kriya Therapeutics highlights the company’s gene therapy programs for geographic atrophy and thyroid eye disease.
Kriya is designing both therapies to be one-time in-office injections.
“We really do believe that gene therapy and genetic medicines will be the future of medicine in a number of different disease areas, and we’re excited to be a part of that,” Ramaswamy said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Ramaswamy reports being the co-founder and CEO of Kriya Therapeutics.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.